Related Experiment Video
Updated: Jul 19, 2026

In vivo Macrophage Imaging Using MR Targeted Contrast Agent for Longitudinal Evaluation of Septic Arthritis
Published on: October 20, 2013
Atypical presentation of macrophagic myofasciitis 10 years post vaccination
Aisling M Ryan1, Niamh Bermingham, Hugh J Harrington
1Department of Neurology, Cork University Hospital, Cork, Ireland. aisling.ryan4@mailp.hse.ie
Abstract:
Macrophagic myofasciitis (MMF) is an uncommon inflammatory disorder of muscle believed to be due to persistence of vaccine-derived aluminium hydroxide at the site of injection. The condition is characterised by diffuse myalgias, arthralgia and fatigue. We describe a patient with histologically confirmed MMF whose presentation was atypical with left chest and upper limb pain beginning more than 10 years post vaccination. Treatment with steroids led to symptomatic improvement. Although rare, clinicians should consider MMF in cases of atypical myalgia.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myasthenia Gravis ll: Pathophysiology
Atypical Pneumonia
Vaccinations
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Rocky Mountain Spotted Fever